Niall C. Tebbutt

University of Melbourne — Australia

Medicine · Health Sciences

65h-index23.9kcitations509works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(262), Gastric Cancer Management and Outcomes(148), Cancer Treatment and Pharmacology(74), Genetic factors in colorectal cancer(66), Cancer Genomics and Diagnostics(65)

Publications509 total

Figure S3 from Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death
2025Open Access
Figure S1 from Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death
2025Open Access
Figure S2 from Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death
2025Open Access
Supplementary Table 1 from Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death
2025Open Access
Figure S5 from Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death
2025Open Access
Figure S4 from Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death
2025Open Access
Supplementary Data DS1 from A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in <i>BRAF</i> V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
2025Open Access
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers
Future Oncology·2025Open Access
Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis
iScience·2025Open Access
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
Nature Medicine·2025· 8 cited
Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer
Clinical & Experimental Metastasis·2025Open Access
LBA80 Regorafenib plus nivolumab vs investigator’s choice of chemotherapy in previously treated gastric or gastroesophageal cancer: INTEGRATE IIb, a randomized phase 3 AGITG Intergroup [NHMRC-CTC/IKF/AIO, ACCRU, TCOG/NHRI] study
Annals of Oncology·2025Open Access
091. MULTI-OMICS EVALUATION OF PERITONEAL FLUID IN GASTROESOPHAGEAL CANCER: RESULTS FROM INTERIM ANALYSIS
Diseases of the Esophagus·2025
Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis
JCO oncology advances.·2025Open Access
260MO AGITG ASCEND study: Randomised, double-blind phase II study of certepetide (CERT) or placebo (PLA) added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Cohort B progression-free survival (PFS) results
Annals of Oncology·2025Open Access
The current landscape of neoadjuvant therapy for resectable colon cancer
Expert Review of Anticancer Therapy·2025· 1 cited
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
Communications Biology·2025· 4 citedOpen Access
Neo-adjuvant chemo-immunotherapy in pancreatic cancer: Results of the Australasian Gastrointestinal Trials Group (AGITG) NEO-IMPACT pilot trial.
Journal of Clinical Oncology·2025
ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG).
Journal of Clinical Oncology·2025· 14 cited
Neoadjuvant intraperitoneal chemotherapy in high-risk and cytology positive gastric cancer: a systematic review
Surgical Oncology·2025· 1 cited
page 1 of 26Next →

Frequent Co-authors

Timothy Price(11), John Zalcberg(10), David Cunningham(10), Christos S. Karapetis(8), Eric Van Cutsem(8), Malcolm J. Moore(7), Alfredo Falcone(7), Derek J. Jonker(6), Nick Pavlakis(6), Dongsheng Tu(5), David Goldstein(5), Josep Tabernero(5), Peter Gibbs(5), R. J. Simes(4), Atsushi Ohtsu(4), Daniel H. Palmer(4), Michel Seymour(4), Volker Heinemann(4), Vinod Ganju(4), Ian Chau(4)